secwatch.observer — SEC 8-K summary
======================================

Issuer:     SKINOVATION PHARMACEUTICAL INC (—)
CIK:        0001118072
Form:       8-K/A
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001554795-24-000051
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skinovation changes auditor: dismisses Pinnacle, appoints Fruci & Associates
----------------------------------------------------------------------------

- Board dismissed Pinnacle Accountancy Group and engaged Fruci & Associates II, PLLC effective January 3, 2024.
- Pinnacle's reports for fiscal years ended Dec 31, 2022 and 2021 contained no adverse opinion or qualification.
- No disagreements with Pinnacle on accounting principles or audit scope during the relevant periods.
- Filing is an amendment to correct the name of the new audit firm.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1118072/000155479524000051/0001554795-24-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1118072/000155479524000051/skin0312form8ka1.htm
  HTML page:      https://secwatch.observer/filing/0001554795-24-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer